Biological simulations in drug discovery

Area of Science:

• Computational biology and systems biology.
• Pharmacology and drug development.
• Physiological modeling.

Background:

• Genetic and molecular sequencing provide foundational data but do not fully capture complex biological system behaviors.
• Understanding integrated system properties requires computational approaches beyond gene-specific information.
• The heart serves as a key example for demonstrating the utility of biological simulation.

Purpose of the Study:

• To illustrate the application of biological simulation in drug discovery, development, and assessment.
• To highlight the versatility of computational modeling across various organs and systems.
• To present the feasibility of creating a comprehensive virtual biological corpus.

Main Methods:

• Development of computational models for biological systems, using the heart as a primary example.
• Extrapolation of modeling techniques to other organs, including neurones, the pancreas, and the lungs.
• Integration of gene-encoded protein properties with interaction data to compute system-level functions.

Main Results:

• Demonstrated successful application of heart modeling in drug discovery, development, and assessment.
• Successfully developed models for neuronal systems, the pancreas, and the lungs, showcasing broad applicability.
• Established the foundational principles for creating a virtual corpus of biological systems.

Conclusions:

• Computational simulation is an essential complement to molecular sequencing for understanding biological systems.
• Modeling technology is readily applicable across diverse organs and physiological systems.
• The ultimate goal of a comprehensive virtual corpus is achievable through integrated system modeling.